TEMOZOLOMIDE

TEMOZOLOMIDE was reported 21320 times

TEMOZOLOMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPERMUTATION 136 0.9714
1 MALIGNANT CRANIAL NERVE NEOPLASM 17 0.6538
2 DESMOPLASTIC SMALL ROUND CELL TUMOUR 47 0.5402
3 DNA MISMATCH REPAIR PROTEIN GENE MUTATION 12 0.5000
4 ANAPLASTIC OLIGODENDROGLIOMA 7 0.3684
5 RETRO-ORBITAL NEOPLASM 17 0.3208
6 GLIOSARCOMA 11 0.3143
7 BRAIN STEM GLIOMA 35 0.2303
8 ANAPLASTIC ASTROCYTOMA 35 0.2121
9 MEDULLOBLASTOMA RECURRENT 23 0.2035
10 GLIOBLASTOMA MULTIFORME 162 0.1924
11 NEUROBLASTOMA RECURRENT 39 0.1921
12 ASTROCYTOMA 74 0.1873
13 GLIOBLASTOMA 312 0.1827
14 ALVEOLAR RHABDOMYOSARCOMA 8 0.1818
15 TUMOUR PSEUDOPROGRESSION 186 0.1699
16 MALIGNANT GLIOMA 24 0.1690
17 GANGLIONEUROMA 11 0.1667
18 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 14 0.1573
19 OLIGODENDROGLIOMA 17 0.1417
20 RADIATION NECROSIS 67 0.1169
21 ASTROCYTOMA MALIGNANT 12 0.1165
22 ANGINA BULLOSA HAEMORRHAGICA 27 0.1164
23 PARATHYROID TUMOUR MALIGNANT 14 0.1094
24 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 24 0.1004
25 OPTIC GLIOMA 9 0.0909
26 EPENDYMOMA 13 0.0897
27 GLIOMA 56 0.0871
28 BRAIN TUMOUR OPERATION 17 0.0850
29 HERPES SIMPLEX ENCEPHALITIS 38 0.0819
30 NEUROBLASTOMA 31 0.0809
31 CORNEAL TOXICITY 8 0.0721
32 HIPPOCAMPAL SCLEROSIS 9 0.0703
33 BLOOD GASTRIN INCREASED 9 0.0703
34 CENTRAL NERVOUS SYSTEM NECROSIS 19 0.0691
35 VASOGENIC CEREBRAL OEDEMA 49 0.0681
36 GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE 7 0.0631
37 NEPHROBLASTOMA 8 0.0630
38 MEDULLOBLASTOMA 9 0.0604
39 ASTROCYTOMA, LOW GRADE 10 0.0588
40 INTRACRANIAL TUMOUR HAEMORRHAGE 22 0.0568
41 VANISHING BILE DUCT SYNDROME 57 0.0511
42 ASPERGILLUS INFECTION 327 0.0498
43 METASTASES TO SPINAL CORD 9 0.0464
44 TUMOUR NECROSIS 47 0.0445
45 PNEUMOCYSTIS JIROVECI INFECTION 12 0.0433
46 VULVAL DISORDER 27 0.0408
47 INSULINOMA 7 0.0395
48 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 49 0.0393
49 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 9 0.0391
50 CRANIOTOMY 16 0.0390
51 PANCREATIC NEUROENDOCRINE TUMOUR 25 0.0390
52 HAEMOGLOBIN 7 0.0352
53 CENTRAL NERVOUS SYSTEM LYMPHOMA 43 0.0312
54 CRYSTAL NEPHROPATHY 18 0.0304
55 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 43 0.0296
56 FACIAL ASYMMETRY 28 0.0294
57 MUSCLE SWELLING 27 0.0293
58 CYTOPENIA 356 0.0290
59 BONE MARROW TOXICITY 33 0.0278
60 APLASTIC ANAEMIA 144 0.0275
61 REFUSAL OF TREATMENT BY RELATIVE 12 0.0265
62 LYMPHOPENIA 367 0.0259
63 ENCEPHALOMALACIA 14 0.0249
64 HAEMATOTOXICITY 228 0.0240
65 DYSPHASIA 11 0.0236
66 CHOLESTATIC LIVER INJURY 51 0.0229
67 NEOPLASM RECURRENCE 75 0.0221
68 METASTASES TO BONE MARROW 11 0.0220
69 CANDIDA TEST POSITIVE 9 0.0215
70 METASTASES TO PERITONEUM 54 0.0214
71 ACQUIRED GENE MUTATION 28 0.0214
72 RADIATION INJURY 22 0.0207
73 BLOOD CHROMOGRANIN A INCREASED 9 0.0196
74 DIABETES INSIPIDUS 47 0.0195
75 RECURRENT CANCER 79 0.0193
76 ENTEROCUTANEOUS FISTULA 17 0.0193
77 PLATELET TRANSFUSION 24 0.0186
78 DISSEMINATED CRYPTOCOCCOSIS 14 0.0185
79 INTRACRANIAL HYPOTENSION 12 0.0184
80 NEUROENDOCRINE TUMOUR 26 0.0183
81 METASTASES TO MENINGES 41 0.0180
82 BRAIN NEOPLASM MALIGNANT 80 0.0179
83 HOSPICE CARE 176 0.0178
84 PNEUMOCYSTIS JIROVECI PNEUMONIA 39 0.0175
85 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 8 0.0172
86 METASTATIC MALIGNANT MELANOMA 39 0.0170
87 TUMOUR HAEMORRHAGE 48 0.0168
88 NEPHROGENIC DIABETES INSIPIDUS 19 0.0165
89 GLIOSIS 7 0.0163
90 HYDROCEPHALUS 88 0.0161
91 BRAIN SCAN ABNORMAL 9 0.0161
92 DISEASE PROGRESSION 1895 0.0160
93 BRAIN OEDEMA 199 0.0157
94 BONE MARROW DEPRESSION 15 0.0154
95 IIIRD NERVE PARALYSIS 12 0.0148
96 SIALOADENITIS 20 0.0147
97 CEREBRAL ASPERGILLOSIS 9 0.0146
98 EARLY SATIETY 28 0.0144
99 THROMBOCYTOPENIA 1592 0.0142
100 ENCEPHALITIS HERPES 7 0.0142
101 THERAPY PARTIAL RESPONDER 220 0.0141
102 BONE MARROW FAILURE 284 0.0140
103 METASTASES TO LIVER 242 0.0138
104 JAW OPERATION 12 0.0135
105 LOBAR PNEUMONIA 25 0.0135
106 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 10 0.0133
107 FAT NECROSIS 8 0.0132
108 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 29 0.0131
109 NEOPLASM PROGRESSION 454 0.0130
110 BRAIN CANCER METASTATIC 9 0.0130
111 METAPNEUMOVIRUS INFECTION 10 0.0128
112 FEBRILE NEUTROPENIA 839 0.0126
113 INTUSSUSCEPTION 12 0.0126
114 ORAL INTAKE REDUCED 30 0.0124
115 SIMPLE PARTIAL SEIZURES 10 0.0124
116 NEUTROPHIL COUNT ABNORMAL 35 0.0124
117 BRAIN OPERATION 28 0.0123
118 GENE MUTATION 24 0.0121
119 METASTASES TO SPINE 40 0.0119
120 NEUROLOGICAL DECOMPENSATION 27 0.0117
121 DRUG CLEARANCE DECREASED 15 0.0115
122 MONOCYTE COUNT DECREASED 14 0.0115
123 TRANSFUSION REACTION 10 0.0114
124 BRAIN NEOPLASM 104 0.0113
125 TUMOUR EXCISION 9 0.0112
126 NONINFECTIVE ENCEPHALITIS 8 0.0111
127 METASTASES TO LYMPH NODES 74 0.0110
128 B-CELL TYPE ACUTE LEUKAEMIA 8 0.0109
129 CREPITATIONS 31 0.0104
130 HEMIPARESIS 174 0.0103
131 CEREBRAL CYST 7 0.0102
132 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 11 0.0100
133 PERIPHERAL MOTOR NEUROPATHY 14 0.0100
134 PELVIC MASS 8 0.0099
135 LIVER ABSCESS 32 0.0099
136 CEREBROSPINAL FLUID LEAKAGE 18 0.0097
137 CENTRAL NERVOUS SYSTEM INFECTION 11 0.0096
138 INTRACRANIAL MASS 9 0.0095
139 WHITE MATTER LESION 12 0.0095
140 SKIN STRIAE 14 0.0094
141 METASTASIS 67 0.0094
142 HEPATIC CANCER METASTATIC 8 0.0093
143 MYELOSUPPRESSION 336 0.0093
144 STRONGYLOIDIASIS 15 0.0093
145 THROMBOPHLEBITIS SUPERFICIAL 28 0.0092
146 MYELITIS TRANSVERSE 13 0.0092
147 MALIGNANT NEOPLASM PROGRESSION 944 0.0092
148 CRYPTOCOCCOSIS 15 0.0092
149 PARTIAL SEIZURES 48 0.0092
150 PANCYTOPENIA 510 0.0091
151 METASTASES TO LUNG 105 0.0091
152 MENINGITIS BACTERIAL 13 0.0091
153 METASTASES TO CENTRAL NERVOUS SYSTEM 117 0.0091
154 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 55 0.0090
155 COMPLEX PARTIAL SEIZURES 10 0.0090
156 PARAPARESIS 16 0.0090
157 OPTIC NEUROPATHY 19 0.0090
158 CD4 LYMPHOCYTES DECREASED 19 0.0089
159 CEREBRAL VENTRICLE DILATATION 10 0.0087
160 POSTOPERATIVE WOUND COMPLICATION 11 0.0086
161 RADIATION SKIN INJURY 10 0.0086
162 BILIARY OBSTRUCTION 11 0.0085
163 PNEUMONIA CRYPTOCOCCAL 8 0.0085
164 CAMPYLOBACTER INFECTION 7 0.0084
165 ASPERGILLOSIS 11 0.0084
166 NEUROLOGICAL SYMPTOM 48 0.0084
167 LYMPHOCYTE COUNT DECREASED 147 0.0083
168 ARRHYTHMIA SUPRAVENTRICULAR 9 0.0082
169 OPPORTUNISTIC INFECTION 15 0.0081
170 HEMIANOPIA 8 0.0081
171 BLOOD ALKALINE PHOSPHATASE ABNORMAL 7 0.0078
172 POSTICTAL STATE 8 0.0077
173 NEUTROPENIA 1041 0.0076
174 RENAL INFARCT 11 0.0076
175 HEPATIC LESION 32 0.0074
176 DIVERTICULAR PERFORATION 15 0.0073
177 PNEUMOCYSTIS JIROVECII PNEUMONIA 72 0.0072
178 COAGULATION TIME PROLONGED 11 0.0071
179 VITH NERVE PARALYSIS 8 0.0070
180 HEPATITIS B REACTIVATION 22 0.0069
181 MENTAL STATUS CHANGES 191 0.0069
182 TONGUE ULCERATION 23 0.0068
183 PACKED RED BLOOD CELL TRANSFUSION 9 0.0068
184 DISEASE RECURRENCE 321 0.0067
185 CANDIDIASIS 27 0.0067
186 PNEUMONIA CYTOMEGALOVIRAL 13 0.0067
187 NOCARDIOSIS 17 0.0066
188 ASPARTATE AMINOTRANSFERASE ABNORMAL 10 0.0066
189 BLOOD PRESSURE DIASTOLIC INCREASED 30 0.0065
190 MYELODYSPLASTIC SYNDROME 94 0.0065
191 FACIAL PALSY 14 0.0065
192 GASTROINTESTINAL TOXICITY 31 0.0064
193 MULTIPLE-DRUG RESISTANCE 20 0.0064
194 IMMUNE THROMBOCYTOPENIC PURPURA 18 0.0064
195 FAILURE TO THRIVE 33 0.0063
196 SPLENIC INFARCTION 11 0.0063
197 MENINGITIS CRYPTOCOCCAL 11 0.0063
198 LEUKOPENIA 314 0.0063
199 BLOOD BILIRUBIN ABNORMAL 8 0.0062
200 EXPOSURE VIA FATHER 8 0.0061
201 LUNG CONSOLIDATION 17 0.0061
202 BRAIN HERNIATION 18 0.0060
203 BLOOD CULTURE POSITIVE 18 0.0060
204 DRUG RESISTANCE 154 0.0060
205 SYSTEMIC CANDIDA 15 0.0060
206 ACUTE MYELOID LEUKAEMIA 93 0.0060
207 OTOTOXICITY 11 0.0059
208 PRODUCT USE IN UNAPPROVED INDICATION 1474 0.0059
209 INTRACRANIAL PRESSURE INCREASED 33 0.0059
210 PARAINFLUENZAE VIRUS INFECTION 9 0.0059
211 HAEMOGLOBIN ABNORMAL 38 0.0059
212 PLATELET COUNT DECREASED 625 0.0059
213 CLOSTRIDIUM COLITIS 7 0.0058
214 ENCEPHALITIS VIRAL 7 0.0057
215 HYPOPITUITARISM 10 0.0057
216 SINUS ARREST 9 0.0057
217 IDIOPATHIC THROMBOCYTOPENIC PURPURA 9 0.0057
218 DRUG TOLERANCE DECREASED 16 0.0057
219 LICHENOID KERATOSIS 13 0.0057
220 CONVULSION 324 0.0057
221 ATAXIA 67 0.0056
222 WHITE BLOOD CELL COUNT ABNORMAL 36 0.0056
223 WOUND DEHISCENCE 19 0.0056
224 HYPERNATRAEMIA 28 0.0056
225 EMBOLISM VENOUS 17 0.0056
226 OESOPHAGITIS 61 0.0056
227 PROTEIN TOTAL DECREASED 21 0.0056
228 PNEUMONIA FUNGAL 22 0.0056
229 PNEUMONIA STAPHYLOCOCCAL 11 0.0056
230 METASTATIC NEOPLASM 24 0.0056
231 OPTIC ATROPHY 9 0.0055
232 ARTERIOSPASM CORONARY 22 0.0055
233 EMBOLISM 45 0.0054
234 LARGE INTESTINE PERFORATION 37 0.0053
235 GASTROINTESTINAL PERFORATION 22 0.0053
236 ATELECTASIS 51 0.0053
237 METASTASES TO BONE 86 0.0052
238 DIFFICULTY IN WALKING 18 0.0052
239 INFREQUENT BOWEL MOVEMENTS 13 0.0052
240 CYTOMEGALOVIRUS COLITIS 12 0.0052
241 PETECHIAE 54 0.0052
242 HAEMORRHAGE INTRACRANIAL 77 0.0051
243 LANGUAGE DISORDER 11 0.0051
244 FUNGAEMIA 8 0.0051
245 RALES 29 0.0050
246 CUSHINGOID 16 0.0050
247 CRANIOCEREBRAL INJURY 15 0.0050
248 MUCOSAL INFLAMMATION 128 0.0049
249 HYPERTRANSAMINASAEMIA 34 0.0049
250 LUNG INFILTRATION 43 0.0049
251 APHASIA 147 0.0049
252 WHITE BLOOD CELL DISORDER 13 0.0049
253 LEUKOENCEPHALOPATHY 18 0.0048
254 HYPOPROTEINAEMIA 9 0.0047
255 BRAIN ABSCESS 12 0.0047
256 NEUTROPHIL COUNT DECREASED 193 0.0047
257 DIFFUSE LARGE B-CELL LYMPHOMA 36 0.0047
258 NECROSIS 26 0.0047
259 MENINGITIS 31 0.0046
260 BODY TEMPERATURE DECREASED 45 0.0046
261 PSEUDOMONAL SEPSIS 8 0.0046
262 HYPOPHOSPHATAEMIA 33 0.0045
263 PULMONARY EMBOLISM 423 0.0044
264 GRAND MAL CONVULSION 41 0.0044
265 COMPUTERISED TOMOGRAM ABNORMAL 10 0.0044
266 HYPOALBUMINAEMIA 34 0.0044
267 NEUTROPENIC SEPSIS 31 0.0043
268 PERFORMANCE STATUS DECREASED 20 0.0043
269 HYPERGLYCAEMIA 156 0.0043
270 VITILIGO 10 0.0043
271 BRONCHOPULMONARY ASPERGILLOSIS 33 0.0043
272 FEBRILE BONE MARROW APLASIA 18 0.0042
273 DEEP VEIN THROMBOSIS 275 0.0042
274 ANTIBODY TEST POSITIVE 7 0.0042
275 PNEUMATOSIS INTESTINALIS 12 0.0042
276 NEOPLASM 48 0.0042
277 SEIZURE 472 0.0041
278 BLOOD CHLORIDE INCREASED 7 0.0040
279 ANAEMIA 765 0.0040
280 RASH MORBILLIFORM 11 0.0040
281 DEAFNESS NEUROSENSORY 13 0.0039
282 INFECTION 570 0.0039
283 DISEASE COMPLICATION 18 0.0039
284 CANCER PAIN 10 0.0039
285 SMALL INTESTINAL OBSTRUCTION 48 0.0039
286 METHAEMOGLOBINAEMIA 9 0.0039
287 ATRIAL FIBRILLATION 376 0.0039
288 HAEMORRHAGE 401 0.0038
289 BLOOD CALCIUM DECREASED 43 0.0038
290 PULMONARY INFARCTION 9 0.0038
291 ACUTE HEPATIC FAILURE 52 0.0038
292 PLATELET COUNT ABNORMAL 23 0.0038
293 ALANINE AMINOTRANSFERASE ABNORMAL 8 0.0038
294 ASCITES 111 0.0038
295 WOUND INFECTION 41 0.0037
296 PROTEINURIA 71 0.0037
297 HEMIPLEGIA 31 0.0037
298 BLOOD SODIUM INCREASED 10 0.0037
299 VENOOCCLUSIVE LIVER DISEASE 18 0.0036
300 HEPATIC MASS 7 0.0036
301 EMERGENCY CARE 11 0.0036
302 IMMUNOSUPPRESSION 32 0.0036
303 MALNUTRITION 40 0.0036
304 VENOUS THROMBOSIS 14 0.0036
305 CLOSTRIDIAL INFECTION 12 0.0035
306 DISTRIBUTIVE SHOCK 8 0.0035
307 OESOPHAGEAL CANDIDIASIS 14 0.0035
308 NEUROTOXICITY 61 0.0035
309 ALANINE AMINOTRANSFERASE INCREASED 213 0.0035
310 HYPOKALAEMIA 160 0.0035
311 ENTEROCOLITIS 20 0.0035
312 ADRENAL INSUFFICIENCY 42 0.0035
313 HEPATOTOXICITY 77 0.0035
314 THERAPY CHANGE 34 0.0035
315 ORGANISING PNEUMONIA 17 0.0034
316 PNEUMONITIS 93 0.0034
317 BLOOD ALBUMIN DECREASED 27 0.0034
318 FLUID INTAKE REDUCED 17 0.0034
319 FACIAL PARESIS 12 0.0034
320 CAPILLARY LEAK SYNDROME 7 0.0034
321 INTESTINAL PERFORATION 38 0.0034
322 AKINESIA 7 0.0034
323 DEVICE RELATED INFECTION 52 0.0034
324 BLOOD MAGNESIUM DECREASED 29 0.0034
325 ECCHYMOSIS 23 0.0034
326 ACUTE RESPIRATORY DISTRESS SYNDROME 59 0.0033
327 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 11 0.0033
328 NO THERAPEUTIC RESPONSE 40 0.0033
329 ANOREXIA 42 0.0033
330 DRUG TOXICITY 44 0.0032
331 SEPSIS 360 0.0032
332 HEPATIC CYTOLYSIS 41 0.0032
333 CEREBRAL HAEMORRHAGE 115 0.0032
334 PLATELET DISORDER 8 0.0032
335 FACIAL PARALYSIS 27 0.0032
336 ERYTHEMA MULTIFORME 29 0.0031
337 WHITE BLOOD CELL COUNT DECREASED 337 0.0031
338 BLOOD CHLORIDE DECREASED 8 0.0031
339 SUSPECTED OFF LABEL USE 14 0.0031
340 SPINAL CORD COMPRESSION 12 0.0031
341 BLOOD BILIRUBIN INCREASED 83 0.0031
342 NEPHROTIC SYNDROME 21 0.0031
343 STATUS EPILEPTICUS 34 0.0030
344 SKIN TOXICITY 17 0.0030
345 METABOLIC ENCEPHALOPATHY 9 0.0030
346 HYPERBILIRUBINAEMIA 31 0.0030
347 MIXED LIVER INJURY 9 0.0030
348 HEPATITIS B 18 0.0030
349 ABDOMINAL MASS 8 0.0030
350 PULMONARY TOXICITY 21 0.0030
351 ORAL CANDIDIASIS 39 0.0030
352 HYPONATRAEMIA 166 0.0029
353 EOSINOPHIL COUNT DECREASED 7 0.0029
354 NEPHROPATHY TOXIC 33 0.0029
355 TYPE IV HYPERSENSITIVITY REACTION 8 0.0029
356 REFUSAL OF TREATMENT BY PATIENT 19 0.0029
357 AGRANULOCYTOSIS 54 0.0029
358 CHOLECYSTITIS INFECTIVE 8 0.0029
359 SEPTIC SHOCK 125 0.0029
360 ASPARTATE AMINOTRANSFERASE INCREASED 152 0.0029
361 COGNITIVE DISORDER 133 0.0028
362 CLOSTRIDIUM DIFFICILE INFECTION 62 0.0028
363 CLOSTRIDIUM DIFFICILE COLITIS 30 0.0028
364 HAEMATOCRIT DECREASED 56 0.0028
365 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
366 INTRAVENTRICULAR HAEMORRHAGE 7 0.0028
367 ENTERITIS 18 0.0028
368 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 65 0.0028
369 INCOHERENT 18 0.0028
370 BACTERAEMIA 33 0.0028
371 MYOPATHY 24 0.0028
372 BLOOD LACTATE DEHYDROGENASE INCREASED 44 0.0028
373 PARAPLEGIA 8 0.0028
374 FINE MOTOR SKILL DYSFUNCTION 8 0.0028
375 BACTERIAL SEPSIS 9 0.0028
376 DYSLIPIDAEMIA 14 0.0028
377 CACHEXIA 14 0.0027
378 EPILEPSY 83 0.0027
379 MALIGNANT MELANOMA 36 0.0027
380 POTENTIATING DRUG INTERACTION 9 0.0027
381 PROTHROMBIN TIME PROLONGED 16 0.0027
382 HEPATITIS CHOLESTATIC 16 0.0027
383 HEPATIC NECROSIS 10 0.0027
384 PULSELESS ELECTRICAL ACTIVITY 11 0.0026
385 BREAST PAIN 28 0.0026
386 DEHYDRATION 350 0.0026
387 AREFLEXIA 7 0.0026
388 HAEMORRHOIDS 51 0.0026
389 PNEUMONIA ASPIRATION 65 0.0026
390 NERVE COMPRESSION 24 0.0026
391 HYPERTRIGLYCERIDAEMIA 15 0.0026
392 ESCHERICHIA INFECTION 21 0.0026
393 ELECTROENCEPHALOGRAM ABNORMAL 8 0.0025
394 TRANSAMINASES INCREASED 56 0.0025
395 COORDINATION ABNORMAL 35 0.0025
396 ILEUS 31 0.0025
397 VENTRICULAR HYPOKINESIA 8 0.0025
398 ABDOMINAL ABSCESS 11 0.0025
399 MONOCYTE COUNT INCREASED 9 0.0025
400 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 63 0.0024
401 ENCEPHALOPATHY 60 0.0024
402 HYPOGAMMAGLOBULINAEMIA 16 0.0024
403 ESCHERICHIA SEPSIS 7 0.0024
404 DRUG-INDUCED LIVER INJURY 75 0.0024
405 BLOOD COUNT ABNORMAL 36 0.0024
406 BLOOD DISORDER 19 0.0024
407 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 12 0.0024
408 MASS 33 0.0024
409 B-CELL LYMPHOMA 8 0.0024
410 PALLOR 64 0.0023
411 LUNG NEOPLASM 10 0.0023
412 CONFUSIONAL STATE 378 0.0023
413 BLOOD ALKALINE PHOSPHATASE INCREASED 58 0.0023
414 CEREBRAL ISCHAEMIA 12 0.0023
415 HEPATIC FIBROSIS 8 0.0023
416 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 22 0.0023
417 GAMMA-GLUTAMYLTRANSFERASE INCREASED 51 0.0023
418 DERMATITIS ACNEIFORM 14 0.0023
419 CHOLECYSTITIS ACUTE 13 0.0023
420 CHEST X-RAY ABNORMAL 7 0.0023
421 HYPOXIA 80 0.0023
422 SUBARACHNOID HAEMORRHAGE 23 0.0023
423 LETHARGY 129 0.0022
424 TUBULOINTERSTITIAL NEPHRITIS 42 0.0022
425 METABOLIC DISORDER 13 0.0022
426 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0022
427 STAPHYLOCOCCAL SEPSIS 11 0.0022
428 COLITIS 84 0.0022
429 THERAPY CESSATION 113 0.0022
430 GENERALISED TONIC-CLONIC SEIZURE 36 0.0022
431 TOXIC EPIDERMAL NECROLYSIS 33 0.0022
432 ENCEPHALITIS 15 0.0022
433 URINARY INCONTINENCE 64 0.0022
434 CONSTIPATION 471 0.0022
435 HYPOPHAGIA 55 0.0021
436 HEPATIC NEOPLASM 7 0.0021
437 HEPATIC ENCEPHALOPATHY 20 0.0021
438 RESPIRATORY RATE INCREASED 19 0.0021
439 HEPATOMEGALY 21 0.0021
440 HAEMOLYTIC ANAEMIA 19 0.0021
441 HEPATIC PAIN 9 0.0021
442 VOMITING 991 0.0021
443 CYTOMEGALOVIRUS INFECTION 35 0.0021
444 DEATH 1811 0.0021
445 OFF LABEL USE 1833 0.0021
446 HAEMOGLOBIN DECREASED 213 0.0021
447 POISONING 26 0.0021
448 THERAPY NON-RESPONDER 93 0.0021
449 HYPOCALCAEMIA 39 0.0021
450 DISORIENTATION 81 0.0020
451 DRUG ERUPTION 36 0.0020
452 CHOLELITHIASIS 66 0.0020
453 MENINGITIS ASEPTIC 9 0.0020
454 LOGORRHOEA 7 0.0020
455 CYSTITIS HAEMORRHAGIC 8 0.0020
456 ELECTROLYTE IMBALANCE 23 0.0020
457 CHOLESTASIS 38 0.0020
458 FIBRIN D DIMER INCREASED 7 0.0020
459 DECUBITUS ULCER 16 0.0020
460 REBOUND EFFECT 22 0.0019
461 HYPERURICAEMIA 8 0.0019
462 LEUKOCYTOSIS 35 0.0019
463 ACUTE RESPIRATORY FAILURE 37 0.0019
464 RESPIRATORY DISTRESS 53 0.0019
465 RESPIRATORY FAILURE 140 0.0019
466 RENAL FAILURE ACUTE 81 0.0019
467 CARDIOTOXICITY 17 0.0019
468 HEPATIC FUNCTION ABNORMAL 71 0.0019
469 INCONTINENCE 20 0.0019
470 SUBDURAL HAEMATOMA 27 0.0019
471 AORTIC VALVE INCOMPETENCE 8 0.0019
472 MUSCULOSKELETAL CHEST PAIN 29 0.0019
473 OSTEONECROSIS OF JAW 46 0.0019
474 CHEMOTHERAPY 7 0.0018
475 DISSEMINATED INTRAVASCULAR COAGULATION 26 0.0018
476 FAECES DISCOLOURED 40 0.0018
477 FACE INJURY 7 0.0018
478 DYSARTHRIA 69 0.0018
479 URINE OUTPUT DECREASED 16 0.0018
480 OEDEMA 99 0.0018
481 PYREXIA 628 0.0018
482 DRUG LEVEL INCREASED 30 0.0018
483 VISUAL FIELD DEFECT 13 0.0018
484 CARDIOPULMONARY FAILURE 7 0.0018
485 MOTOR DYSFUNCTION 18 0.0018
486 BLOOD PRESSURE DIASTOLIC DECREASED 13 0.0018
487 PLEURAL EFFUSION 107 0.0018
488 CEREBRAL ATROPHY 7 0.0018
489 GRANULOCYTOPENIA 10 0.0018
490 VISUAL DISTURBANCE 10 0.0017
491 ASTHENIA 649 0.0017
492 HYPOMAGNESAEMIA 24 0.0017
493 RED BLOOD CELL COUNT DECREASED 49 0.0017
494 PERIPHERAL SENSORY NEUROPATHY 10 0.0017
495 DEMYELINATION 7 0.0017
496 ABASIA 42 0.0017
497 PROCEDURAL COMPLICATION 13 0.0017
498 PHARYNGOLARYNGEAL PAIN 9 0.0017
499 BLOOD PRESSURE SYSTOLIC INCREASED 33 0.0017
500 HEPATIC FAILURE 51 0.0017
501 MUSCULAR WEAKNESS 192 0.0017
502 NAUSEA 1332 0.0017
503 SPEECH DISORDER 88 0.0017
504 GENERAL PHYSICAL HEALTH DETERIORATION 194 0.0017
505 BLOOD UREA INCREASED 28 0.0017
506 EPISTAXIS 124 0.0017
507 PULMONARY THROMBOSIS 18 0.0016
508 DEPRESSED LEVEL OF CONSCIOUSNESS 65 0.0016
509 THROMBOTIC MICROANGIOPATHY 16 0.0016
510 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 90 0.0016
511 PNEUMOTHORAX 26 0.0016
512 TRICUSPID VALVE INCOMPETENCE 13 0.0016
513 TACHYPNOEA 22 0.0016
514 ABDOMINAL TENDERNESS 8 0.0016
515 HYDRONEPHROSIS 12 0.0016
516 NERVOUS SYSTEM DISORDER 50 0.0016
517 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 12 0.0016
518 FULL BLOOD COUNT DECREASED 32 0.0016
519 POLYURIA 13 0.0016
520 DYSPHAGIA 150 0.0016
521 CYTOMEGALOVIRUS VIRAEMIA 7 0.0016
522 LIPASE INCREASED 12 0.0016
523 FEMORAL NECK FRACTURE 8 0.0016
524 ANAL INCONTINENCE 14 0.0016
525 HYPERCHOLESTEROLAEMIA 15 0.0016
526 ASPIRATION 17 0.0016
527 SKIN WARM 9 0.0015
528 TOXICITY TO VARIOUS AGENTS 260 0.0015
529 HERPES SIMPLEX 10 0.0015
530 HYPOVOLAEMIA 9 0.0015
531 CENTRAL NERVOUS SYSTEM LESION 21 0.0015
532 RASH MACULO-PAPULAR 34 0.0015
533 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
534 BLOOD LACTIC ACID INCREASED 8 0.0015
535 MULTIPLE ORGAN DYSFUNCTION SYNDROME 43 0.0015
536 LOCALISED OEDEMA 7 0.0015
537 NYSTAGMUS 8 0.0015
538 SQUAMOUS CELL CARCINOMA 14 0.0015
539 CEREBRAL DISORDER 11 0.0015
540 BLOOD SODIUM DECREASED 28 0.0015
541 FOETAL GROWTH RESTRICTION 9 0.0015
542 DIVERTICULITIS 41 0.0015
543 THROMBOSIS 119 0.0015
544 SINUS TACHYCARDIA 21 0.0015
545 BODY TEMPERATURE INCREASED 30 0.0015
546 GINGIVAL BLEEDING 20 0.0015
547 MOVEMENT DISORDER 47 0.0015
548 HYPOVOLAEMIC SHOCK 7 0.0015
549 DECREASED APPETITE 338 0.0015
550 OLIGURIA 9 0.0014
551 JAUNDICE 39 0.0014
552 HERPES ZOSTER 83 0.0014
553 HAEMODYNAMIC INSTABILITY 11 0.0014
554 SARS-COV-2 TEST POSITIVE 19 0.0014
555 STREPTOCOCCAL INFECTION 8 0.0014
556 TRANSFUSION 15 0.0014
557 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
558 PNEUMONIA BACTERIAL 13 0.0014
559 LUNG INFECTION 22 0.0014
560 HEPATITIS 36 0.0014
561 C-REACTIVE PROTEIN INCREASED 51 0.0014
562 BRAIN INJURY 14 0.0014
563 UNRESPONSIVE TO STIMULI 36 0.0014
564 STEVENS-JOHNSON SYNDROME 31 0.0014
565 BLOOD URIC ACID INCREASED 8 0.0014
566 LIVER INJURY 34 0.0014
567 ALTERED STATE OF CONSCIOUSNESS 30 0.0014
568 DYSPHORIA 7 0.0014
569 ABSCESS 22 0.0014
570 NEUTROPHIL COUNT INCREASED 14 0.0014
571 GROIN PAIN 12 0.0014
572 BLOOD POTASSIUM DECREASED 41 0.0014
573 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 14 0.0014
574 INTENTIONAL PRODUCT USE ISSUE 119 0.0014
575 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 8 0.0013
576 DRUG EFFECT INCOMPLETE 49 0.0013
577 FATIGUE 1050 0.0013
578 DIPLOPIA 35 0.0013
579 PNEUMONIA 436 0.0013
580 LIVER FUNCTION TEST ABNORMAL 39 0.0013
581 TREATMENT FAILURE 111 0.0013
582 GENERAL PHYSICAL CONDITION ABNORMAL 9 0.0013
583 ACUTE KIDNEY INJURY 202 0.0013
584 STOMATITIS 80 0.0013
585 RASH GENERALISED 34 0.0013
586 HOSPITALISATION 201 0.0013
587 DROOLING 9 0.0013
588 POST PROCEDURAL COMPLICATION 25 0.0013
589 PERSONALITY CHANGE 12 0.0013
590 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
591 TACHYCARDIA 114 0.0013
592 PSEUDOMONAS INFECTION 11 0.0013
593 EPSTEIN-BARR VIRUS INFECTION 8 0.0013
594 PULMONARY HAEMORRHAGE 10 0.0013
595 WHITE BLOOD CELL COUNT INCREASED 49 0.0013
596 MANIA 21 0.0013
597 MULTI-ORGAN FAILURE 22 0.0013
598 NIGHT SWEATS 41 0.0013
599 LEUKAEMIA 12 0.0013
600 INTESTINAL ISCHAEMIA 7 0.0013
601 CHILLS 149 0.0013
602 NEEDLE ISSUE 37 0.0013
603 ACTIVITIES OF DAILY LIVING IMPAIRED 25 0.0013
604 ABDOMINAL PAIN 293 0.0013
605 FREQUENT BOWEL MOVEMENTS 34 0.0013
606 PRODUCT USE ISSUE 236 0.0013
607 PROCTALGIA 8 0.0012
608 NEOPLASM MALIGNANT 83 0.0012
609 SENSORY LOSS 10 0.0012
610 DIARRHOEA 801 0.0012
611 BACTERIAL INFECTION 23 0.0012
612 HEAD INJURY 39 0.0012
613 FULL BLOOD COUNT ABNORMAL 13 0.0012
614 DEAFNESS 32 0.0012
615 LIVER DISORDER 54 0.0012
616 THERAPY INTERRUPTED 87 0.0012
617 MEDICAL DEVICE COMPLICATION 9 0.0012
618 GASTROINTESTINAL DISORDER 109 0.0012
619 GENERALISED OEDEMA 15 0.0012
620 CELLULITIS 61 0.0012
621 PULMONARY MASS 18 0.0012
622 SECOND PRIMARY MALIGNANCY 10 0.0012
623 PANCREATITIS ACUTE 27 0.0012
624 SKIN ULCER 31 0.0012
625 PRODUCTIVE COUGH 57 0.0012
626 UROSEPSIS 11 0.0012
627 IMPAIRED HEALING 39 0.0012
628 POSTOPERATIVE WOUND INFECTION 8 0.0012
629 CANDIDA INFECTION 20 0.0012
630 HYPERTHERMIA 9 0.0012
631 URINARY RETENTION 39 0.0012
632 ADVERSE EVENT 107 0.0012
633 URINARY TRACT INFECTION 196 0.0011
634 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
635 HYPOTENSION 230 0.0011
636 DERMATITIS 24 0.0011
637 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 81 0.0011
638 FEEDING DISORDER 23 0.0011
639 HYPERCALCAEMIA 14 0.0011
640 PURPURA 10 0.0011
641 CHOLANGITIS 7 0.0011
642 PHARYNGITIS 14 0.0011
643 MUSCLE TWITCHING 26 0.0011
644 WEIGHT DECREASED 314 0.0011
645 ISCHAEMIC STROKE 20 0.0011
646 HAEMATOMA 29 0.0011
647 HYPERTENSION 237 0.0011
648 PARALYSIS 16 0.0011
649 POST PROCEDURAL HAEMORRHAGE 13 0.0011
650 DRUG INTERACTION 175 0.0011
651 OEDEMA PERIPHERAL 134 0.0011
652 STAPHYLOCOCCAL INFECTION 36 0.0011
653 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 9 0.0011
654 UPPER RESPIRATORY TRACT INFECTION 50 0.0011
655 ANGINA UNSTABLE 7 0.0011
656 BRADYPHRENIA 7 0.0011
657 APPENDICITIS 10 0.0011
658 FALL 355 0.0011
659 HEPATOCELLULAR INJURY 15 0.0011
660 HYPOGLYCAEMIA 51 0.0011
661 GAIT DISTURBANCE 201 0.0010
662 DRUG INTOLERANCE 101 0.0010
663 FEAR 28 0.0010
664 SUDDEN DEATH 11 0.0010
665 PERICARDIAL EFFUSION 24 0.0010
666 EATING DISORDER 22 0.0010
667 APNOEA 8 0.0010
668 ABNORMAL LOSS OF WEIGHT 7 0.0010
669 LIVER FUNCTION TEST INCREASED 22 0.0010
670 CEREBRAL INFARCTION 25 0.0010
671 RENAL TUBULAR NECROSIS 10 0.0010
672 BLOOD CREATININE INCREASED 66 0.0010
673 RENAL CYST 8 0.0010
674 ATRIAL FLUTTER 8 0.0010
675 OSTEOMYELITIS 18 0.0010
676 CONTUSION 95 0.0010
677 BLOOD POTASSIUM INCREASED 16 0.0010
678 DRUG LEVEL DECREASED 10 0.0010
679 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
680 ORTHOSTATIC HYPOTENSION 17 0.0010
681 HYPOTHYROIDISM 31 0.0010
682 TEMPERATURE INTOLERANCE 10 0.0010
683 DRUG INEFFECTIVE 1270 0.0010
684 BALANCE DISORDER 83 0.0010
685 FLANK PAIN 9 0.0010
686 EOSINOPHIL COUNT INCREASED 8 0.0010
687 GASTROENTERITIS 14 0.0010
688 NEUROPATHY PERIPHERAL 91 0.0010
689 HYPERSOMNIA 27 0.0009
690 TASTE DISORDER 19 0.0009
691 GASTROINTESTINAL HAEMORRHAGE 78 0.0009
692 SOMNOLENCE 187 0.0009
693 HEPATIC ENZYME INCREASED 63 0.0009
694 DIABETES MELLITUS 70 0.0009
695 BLOOD PRESSURE DECREASED 61 0.0009
696 COELIAC DISEASE 9 0.0009
697 ACIDOSIS 7 0.0009
698 OSTEONECROSIS 30 0.0009
699 BEDRIDDEN 12 0.0009
700 INTERNATIONAL NORMALISED RATIO INCREASED 26 0.0009
701 PHOTOPHOBIA 17 0.0009
702 BLOOD CREATINE PHOSPHOKINASE INCREASED 26 0.0009
703 INTESTINAL OBSTRUCTION 34 0.0009
704 HYPOTONIA 9 0.0009
705 FLATULENCE 51 0.0009
706 TOXIC SKIN ERUPTION 9 0.0009
707 DELIRIUM 31 0.0009
708 SKIN INFECTION 10 0.0009
709 DYSSTASIA 26 0.0009
710 HEADACHE 557 0.0009
711 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 26 0.0009
712 CYST 11 0.0009
713 FURUNCLE 7 0.0009
714 RASH PRURITIC 47 0.0009
715 NEURALGIA 21 0.0009
716 HEPATIC STEATOSIS 16 0.0009
717 OXYGEN SATURATION DECREASED 48 0.0009
718 HAEMATURIA 29 0.0008
719 DIALYSIS 12 0.0008
720 AMNESIA 55 0.0008
721 ILL-DEFINED DISORDER 51 0.0008
722 IMMUNE SYSTEM DISORDER 11 0.0008
723 PANCREATITIS 44 0.0008
724 SYNCOPE 83 0.0008
725 PRODUCT USE COMPLAINT 13 0.0008
726 DYSPNOEA EXERTIONAL 31 0.0008
727 RESPIRATORY DEPRESSION 10 0.0008
728 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 58 0.0008
729 DENTAL CARIES 9 0.0008
730 IMMUNODEFICIENCY 12 0.0008
731 EOSINOPHILIA 14 0.0008
732 RETCHING 17 0.0008
733 MITRAL VALVE INCOMPETENCE 9 0.0008
734 ABDOMINAL DISTENSION 83 0.0008
735 DERMATITIS ALLERGIC 10 0.0008
736 RASH ERYTHEMATOUS 38 0.0008
737 PRURITUS GENERALISED 17 0.0008
738 MENTAL IMPAIRMENT 19 0.0008
739 PRESYNCOPE 19 0.0008
740 GASTROINTESTINAL INFECTION 7 0.0008
741 DEVELOPMENTAL DELAY 7 0.0008
742 FACE OEDEMA 13 0.0008
743 BRONCHOSPASM 11 0.0008
744 RECTAL HAEMORRHAGE 33 0.0008
745 RENAL IMPAIRMENT 64 0.0008
746 PULMONARY ARTERIAL HYPERTENSION 11 0.0008
747 CHOLECYSTITIS 9 0.0008
748 HYPERLIPIDAEMIA 9 0.0008
749 HAEMOPTYSIS 21 0.0008
750 VIRAL INFECTION 25 0.0008
751 SENSORY DISTURBANCE 12 0.0007
752 LACERATION 7 0.0007
753 DECREASED ACTIVITY 8 0.0007
754 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
755 CARDIOMEGALY 9 0.0007
756 RESPIRATORY TRACT INFECTION 19 0.0007
757 MEMORY IMPAIRMENT 100 0.0007
758 VENTRICULAR TACHYCARDIA 12 0.0007
759 COAGULOPATHY 12 0.0007
760 HAEMATEMESIS 18 0.0007
761 RASH 309 0.0007
762 CHEST PAIN 131 0.0007
763 BLOOD GLUCOSE ABNORMAL 13 0.0007
764 SURGERY 41 0.0007
765 HIATUS HERNIA 9 0.0007
766 PULMONARY OEDEMA 31 0.0007
767 ULCER 11 0.0007
768 HYPERTHYROIDISM 10 0.0007
769 CARDIAC ARREST 57 0.0007
770 PRODUCT PRESCRIBING ISSUE 15 0.0007
771 SWELLING 64 0.0007
772 BONE PAIN 40 0.0007
773 ABNORMAL BEHAVIOUR 27 0.0007
774 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
775 LUNG DISORDER 33 0.0007
776 NO ADVERSE EVENT 121 0.0007
777 URTICARIA 110 0.0007
778 RENAL FAILURE 86 0.0006
779 CONJUNCTIVITIS 12 0.0006
780 INCORRECT PRODUCT ADMINISTRATION DURATION 14 0.0006
781 BRADYCARDIA 34 0.0006
782 INTERSTITIAL LUNG DISEASE 31 0.0006
783 AGITATION 47 0.0006
784 TREATMENT NONCOMPLIANCE 35 0.0006
785 SKIN REACTION 9 0.0006
786 FRACTURE 12 0.0006
787 DYSGEUSIA 47 0.0006
788 BLOOD URINE PRESENT 12 0.0006
789 FUNGAL INFECTION 21 0.0006
790 COMA 30 0.0006
791 HYPERKALAEMIA 22 0.0006
792 ORAL PAIN 14 0.0006
793 LYMPHADENOPATHY 22 0.0006
794 UNDERDOSE 45 0.0006
795 PLATELET COUNT INCREASED 8 0.0006
796 DYSPNOEA 347 0.0006
797 DISTURBANCE IN ATTENTION 33 0.0006
798 LABORATORY TEST ABNORMAL 18 0.0006
799 DYSPEPSIA 60 0.0006
800 CARDIOMYOPATHY 9 0.0006
801 GASTRITIS 16 0.0006
802 BLOOD PRESSURE ABNORMAL 12 0.0006
803 ACCIDENTAL OVERDOSE 22 0.0006
804 AGEUSIA 15 0.0006
805 HYPOAESTHESIA 90 0.0006
806 MOBILITY DECREASED 43 0.0006
807 GAIT INABILITY 20 0.0006
808 CONDITION AGGRAVATED 180 0.0006
809 FLUID RETENTION 30 0.0006
810 COUGH 164 0.0006
811 BURNING SENSATION 41 0.0006
812 ABDOMINAL PAIN UPPER 120 0.0006
813 PERIPHERAL COLDNESS 8 0.0006
814 RASH PAPULAR 13 0.0006
815 LOCALISED INFECTION 14 0.0006
816 THERAPEUTIC RESPONSE DECREASED 35 0.0006
817 BACK PAIN 134 0.0006
818 RESTLESSNESS 21 0.0006
819 SEDATION 15 0.0006
820 MOUTH ULCERATION 12 0.0006
821 EAR PAIN 11 0.0006
822 CYSTITIS 18 0.0006
823 ORAL HERPES 11 0.0006
824 CARDIOGENIC SHOCK 8 0.0006
825 CHEST DISCOMFORT 57 0.0006
826 ARRHYTHMIA 26 0.0005
827 DEPRESSED MOOD 29 0.0005
828 RASH MACULAR 19 0.0005
829 CEREBROVASCULAR ACCIDENT 92 0.0005
830 DIABETIC KETOACIDOSIS 13 0.0005
831 ERYTHEMA 109 0.0005
832 HYPERSENSITIVITY 98 0.0005
833 CARDIO-RESPIRATORY ARREST 22 0.0005
834 PAIN IN EXTREMITY 155 0.0005
835 HALLUCINATION, VISUAL 11 0.0005
836 DYSURIA 19 0.0005
837 MUSCULOSKELETAL PAIN 27 0.0005
838 CYANOSIS 8 0.0005
839 PRODUCT DISPENSING ERROR 11 0.0005
840 RESPIRATORY DISORDER 15 0.0005
841 LOSS OF CONSCIOUSNESS 64 0.0005
842 VERTIGO 30 0.0005
843 HOT FLUSH 37 0.0005
844 PAIN 301 0.0005
845 ALOPECIA 96 0.0005
846 DRUG ADMINISTRATION ERROR 15 0.0005
847 ANAPHYLACTIC REACTION 27 0.0005
848 PERITONITIS 10 0.0005
849 HYPOKINESIA 7 0.0005
850 FLUID OVERLOAD 7 0.0005
851 SKIN DISORDER 16 0.0005
852 ADVERSE DRUG REACTION 43 0.0005
853 SHOCK 11 0.0005
854 MOOD ALTERED 13 0.0005
855 SWELLING FACE 31 0.0005
856 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
857 MUSCULOSKELETAL DISORDER 9 0.0005
858 RESPIRATORY ARREST 13 0.0005
859 HAEMATOCHEZIA 26 0.0005
860 BLOOD PRESSURE INCREASED 72 0.0005
861 METABOLIC ACIDOSIS 15 0.0005
862 BLINDNESS 19 0.0005
863 HYPOACUSIS 20 0.0005
864 POOR QUALITY SLEEP 10 0.0005
865 TREMOR 77 0.0005
866 LACTIC ACIDOSIS 15 0.0005
867 FLUSHING 47 0.0005
868 PERIPHERAL SWELLING 71 0.0005
869 ABDOMINAL DISCOMFORT 77 0.0005
870 DRUG DISPENSING ERROR 7 0.0005
871 TINNITUS 21 0.0005
872 POLLAKIURIA 19 0.0005
873 VISION BLURRED 62 0.0005
874 GALLBLADDER DISORDER 8 0.0004
875 VISUAL IMPAIRMENT 55 0.0004
876 GASTROENTERITIS VIRAL 8 0.0004
877 PRODUCT AVAILABILITY ISSUE 10 0.0004
878 PARAESTHESIA 69 0.0004
879 SKIN LESION 12 0.0004
880 ANGIOEDEMA 19 0.0004
881 THINKING ABNORMAL 8 0.0004
882 RENAL DISORDER 20 0.0004
883 DIZZINESS 214 0.0004
884 MALAISE 186 0.0004
885 VISUAL ACUITY REDUCED 14 0.0004
886 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
887 BLOOD GLUCOSE INCREASED 78 0.0004
888 HEART RATE INCREASED 41 0.0004
889 PRODUCT DOSE OMISSION 27 0.0004
890 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
891 UNEVALUABLE EVENT 31 0.0004
892 PSYCHOTIC DISORDER 12 0.0004
893 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 73 0.0004
894 DEMENTIA 11 0.0004
895 BLISTER 22 0.0004
896 MUSCLE SPASMS 71 0.0004
897 INSOMNIA 101 0.0004
898 INJECTION SITE SWELLING 29 0.0004
899 MEDICATION ERROR 21 0.0004
900 NECK PAIN 21 0.0004
901 NEPHROLITHIASIS 17 0.0004
902 HEART RATE DECREASED 13 0.0004
903 SKIN DISCOLOURATION 17 0.0004
904 SKIN EXFOLIATION 31 0.0004
905 ARTHRALGIA 150 0.0004
906 HALLUCINATION 27 0.0004
907 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
908 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
909 CHROMATURIA 8 0.0004
910 EXPOSURE DURING PREGNANCY 22 0.0004
911 WEIGHT INCREASED 79 0.0004
912 CYTOKINE RELEASE SYNDROME 7 0.0003
913 CARDIAC FAILURE CONGESTIVE 28 0.0003
914 PRODUCT SUBSTITUTION ISSUE 20 0.0003
915 OROPHARYNGEAL PAIN 32 0.0003
916 RHINORRHOEA 22 0.0003
917 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
918 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
919 DRY MOUTH 27 0.0003
920 FOETAL EXPOSURE DURING PREGNANCY 27 0.0003
921 NASOPHARYNGITIS 60 0.0003
922 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
923 HIP FRACTURE 10 0.0003
924 PRURITUS 119 0.0003
925 ANXIETY 88 0.0003
926 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
927 ACUTE MYOCARDIAL INFARCTION 9 0.0003
928 AGGRESSION 15 0.0003
929 ABORTION SPONTANEOUS 12 0.0003
930 CARDIAC FAILURE 24 0.0003
931 MENTAL DISORDER 13 0.0003
932 INTENTIONAL PRODUCT MISUSE 26 0.0003
933 EYE SWELLING 11 0.0003
934 DRY SKIN 39 0.0003
935 OVERDOSE 63 0.0003
936 DYSPHONIA 17 0.0003
937 INFLAMMATION 15 0.0003
938 MYALGIA 49 0.0003
939 SWOLLEN TONGUE 9 0.0003
940 DEPRESSION 65 0.0003
941 BRONCHITIS 21 0.0003
942 COVID-19 49 0.0003
943 ABDOMINAL PAIN LOWER 7 0.0003
944 PREMATURE BABY 8 0.0003
945 LIMB DISCOMFORT 8 0.0003
946 FEMUR FRACTURE 8 0.0003
947 FEELING ABNORMAL 61 0.0003
948 INCORRECT DOSE ADMINISTERED 58 0.0003
949 SINUSITIS 26 0.0003
950 EYE PAIN 14 0.0002
951 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
952 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
953 INJECTION SITE ERYTHEMA 30 0.0002
954 SLEEP DISORDER 17 0.0002
955 LIP SWELLING 8 0.0002
956 BLOOD CHOLESTEROL INCREASED 11 0.0002
957 DRUG DOSE OMISSION 39 0.0002
958 CARDIAC DISORDER 22 0.0002
959 INFLUENZA LIKE ILLNESS 19 0.0002
960 PALPITATIONS 27 0.0002
961 HYPERHIDROSIS 29 0.0002
962 DYSKINESIA 9 0.0002
963 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
964 LUNG NEOPLASM MALIGNANT 9 0.0002
965 INJECTION SITE MASS 8 0.0002
966 EYE DISORDER 7 0.0002
967 INFUSION RELATED REACTION 14 0.0002
968 BLOOD GLUCOSE DECREASED 10 0.0002
969 MYOCARDIAL INFARCTION 35 0.0002
970 INJECTION SITE PAIN 61 0.0002
971 ARTHROPATHY 11 0.0002
972 ROAD TRAFFIC ACCIDENT 8 0.0002
973 INFLUENZA 21 0.0002
974 INJURY 13 0.0002
975 ILLNESS 19 0.0002
976 IRRITABILITY 11 0.0002
977 DISCOMFORT 10 0.0002
978 FEELING HOT 10 0.0002
979 JOINT SWELLING 19 0.0002
980 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
981 NERVOUSNESS 8 0.0002
982 PRODUCT DOSE OMISSION ISSUE 42 0.0001
983 ARTHRITIS 11 0.0001
984 PRODUCT STORAGE ERROR 11 0.0001
985 PRODUCT QUALITY ISSUE 17 0.0001
986 MIGRAINE 11 0.0001
987 INJECTION SITE HAEMORRHAGE 9 0.0001
988 MUSCULOSKELETAL STIFFNESS 9 0.0001
989 ACNE 7 0.0001
990 CHRONIC KIDNEY DISEASE 7 0.0001
991 ASTHMA 10 0.0001
992 BREAST CANCER 8 0.0001
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
994 EMOTIONAL DISTRESS 8 0.0001
995 PSORIASIS 8 0.0001